Gilead

Deja tu Huella prevents up to 8,000 HIV infections through emergency room diagnosis

The Spanish Society of Emergency Medicine (Semes), together with Gilead and other partners such as INFURG-Semes and Seimc, presented the…

3 days ago

Gilead Announces Full Effectiveness of Six-Year Subcutaneous Lenacapavir in HIV Prevention

Gilead presented results from the third phase of the Purpose 1 clinical trial, which assessed the effectiveness of a six-month…

5 months ago

Deja tu Huella: success: one in five people are diagnosed with HIV in the emergency department

The XXXIV Congress of the Spanish Society of Emergency Medicine (Semes), held in Seville, highlighted the success of the Deja…

6 months ago

Nurses demand more HIV training

CompilationAlmost half of new HIV diagnoses are detected late, as stated in the latest HIV and AIDS surveillance report in…

9 months ago

Eliminating hepatitis C requires interdisciplinary work to identify hidden cases

Since launch 'Hepatitis C Strategic Plan(HCV) have been reported in Spain cured more than 165,731 patients with a cure rate…

9 months ago

Spain could become one of the first countries to eliminate hepatitis C | Leader in Social Information

Since the launch of the Hepatitis C (HCV) Strategic Plan, more than 165,731 patients have been treated in Spain, with…

9 months ago